Download Summary-of-Meaningful-Use-Requirements

Summary of Meaningful Use Requirements

15 Mandatory Core Set Objectives :
 Use computerized order entry for medication orders.
 Implement drug-drug, drug-allergy checks.
 Generate and transmit permissible prescriptions electronically.
 Record demographics.
 Maintain an up-to-date problem list of current and active diagnoses.
 Maintain active medication list.
 Maintain active medication allergy list.
 Record and chart changes in vital signs.
 Record smoking status for patients 13 years old or older.
 Implement one clinical decision support rule.
 Report ambulatory quality measures to CMS or the States.
 Provide patients with an electronic copy of their health information upon request.
 Provide clinical summaries to patients for each office visit.
 Capability to exchange key clinical information electronically among providers and patient
authorized entities.
 Protect electronic health information (privacy & security)


Must meet any 5 of the MU Menu Set Objectives listed below:
(Must include at least one of the population health and public health measures)
 Implement drug-formulary checks.
 Incorporate clinical lab-test results into certified EHR as structured data.
 Generate lists of patients by specific conditions to use for quality improvement, reduction of
disparities, research, and outreach.
 Send reminders to patients per patient preference for preventive/ follow-up care
 Provide patients with timely electronic access to their health information (including lab
results, problem list, medication lists, allergies)
 Use certified EHR to identify patient-specific education resources and provide to patient if
appropriate.
 Perform medication reconciliation as relevant
 Provide summary care record for transitions in care or referrals.
 Capability to submit electronic data to immunization registries and actual submission.
 Capability to provide electronic syndromic surveillance data to public health agencies and
actual transmission.
www.corecoc.org
855.241.1145
1120 W. La Veta Ave. Orange CA. 92868 Page 1
The CalOptima Regional Extension Center is a federally-designated Regional Extension Center funded by the Office of the National
Coordinator, Department of Health and Human Services, Award Number: 90RC0066
 Must track the 3 required core CQM below or the alternatives below on patients.
Core Set:
 Hypertension: blood pressure management
 Tobacco use assessment and intervention
 Adult weight screening and follow up
Alternative Set:
 Weight Assessment and Counseling for children and Adolescents
 Influenza Immunization for Patients > 50 years old.
 Childhood Immunization Status










Must identify 3 additional CQM from the set of 38 CQM’s that you commit to track on your
patients.
Diabetes: Hemoglobin A1c poor control
Diabetes: Hemoglobin A1c Control (8.0%)
Diabetes: Low Density Lipoprotein (LDL) Management and Control
Diabetes: Blood pressure management
Diabetes: Eye Exam
Diabetes: Urine Screening
Diabetes: Foot Exam
Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of
Severity of Retinopathy.
Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care.
 Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
 Controlling High Blood Pressure
 Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker
(ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
 Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation.
 Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial
Infarction (MI)
 Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD.
 Coronary Artery Disease (CAD) Drug Therapy for Lowering LDL-Cholesterol
 Ischemic Vascular Disease (IVD): Blood Pressure Management
 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic.
 Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control.
www.corecoc.org
855.241.1145
1120 W. La Veta Ave. Orange CA. 92868 Page 2
The CalOptima Regional Extension Center is a federally-designated Regional Extension Center funded by the Office of the National
Coordinator, Department of Health and Human Services, Award Number: 90RC0066
 Use of Appropriate Medications for Asthma
 Asthma Pharmacologic Therapy
 Asthma Assessment
 Appropriate Testing for Children with Pharyngitis
 Initiation and Engagement of Alcohol and Other Drug
 Dependence Treatment:
a. Initiation
b. Engagement
 Smoking and Tobacco Use Cessation, Medical assistance:
a. Advising Smoking and Tobacco Users to Quit
b. Discussing Smoking and Tobacco Use Cessation Medications
c. Discussing Smoking and Tobacco Use Cessation Strategies
 Anti-depressant medications management
a. Effective Acute Phase Treatment
b. Effective Continuation Phase Treatment
 Pneumonia Vaccination Status for Older Adults
 Breast Cancer Screening
 Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone
Receptor (ER/PR) Positive Breast Cancer
 Colorectal Cancer Screening
 Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer
Patients.
 Cervical Cancer Screening
 Chlamydia Screening for Women
 Prenatal Care: Anti-D Immune Globulin
 Prenatal Care: Screening for human Immunodeficiency virus (HIV)
 Low Back Pain: Use of Imaging Studies
www.corecoc.org
855.241.1145
1120 W. La Veta Ave. Orange CA. 92868 Page 3
The CalOptima Regional Extension Center is a federally-designated Regional Extension Center funded by the Office of the National
Coordinator, Department of Health and Human Services, Award Number: 90RC0066